Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.
Sec. Clinical Microbiology
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1437665
This article is part of the Research Topic Application and Reliability Assessment of Next Generation Sequencing (NGS) and targeted NGS (tNGS) in the Diagnosis of Infectious Diseases-Volume III View all 35 articles

Metagenomic next-generation sequencing for the clinical identification of spinal infection-associated pathogens

Provisionally accepted
Tengfei Shi Tengfei Shi Yuhan Lin Yuhan Lin *Xuexin Zheng Xuexin Zheng *Hongliang Ruan Hongliang Ruan *Rui Zhang Rui Zhang *Yinhuan Liu Yinhuan Liu *Shaohan Xu Shaohan Xu *Huafeng Wang Huafeng Wang *
  • Fuzhou Second General Hospital, Fuzhou, China

The final, formatted version of the article will be published soon.

    Background: This study aimed to evaluate the efficacy of metagenomic next-generation sequencing (mNGS) technology for identifying pathogens associated with spinal infection (SI). Methods: A retrospective analysis was conducted on clinical data from 193 patients with suspected SI between August 2020 and September 2024. Based on histopathological results, the patients were divided into the SI group (n=162) and the non-SI group (n=31). The diagnostic performance of mNGS technology was compared with that of laboratory examination, imaging examination, and microbial culture.Results: Among SI group, mNGS detected 135 pathogens in 77.78% (126/162) of the cases, including nine cases of multiple infections. One or more pathogens were detected using mNGS in 86 patients with SI and negative microbial cultures. Staphylococcus aureus (22.22%, n=30) and Mycobacterium tuberculosis (22.22%, n=30) were the major pathogens, while various rare pathogens such as anaerobes, Brucella, and Coxiella burnetii were also detected. For the 40 cases with positive results for both culture-and mNGS-based identification, high consistency (77.50%) was observed.Antibiotic use did not significantly affect the mNGS detection rate (P = 0.45). There was no significant difference in the positivity rate of mNGS between CT-guided needle biopsy (80.00%) and surgical sampling (77.17%) (P = 0.72). The sensitivity of mNGS (77.78%) was significantly higher than that of traditional microbial culture (27.16%), and the specificity was similar (90.32% vs. 96.77%). Although the sensitivities of erythrocyte sedimentation rate-based assay (91.36%), magnetic resonance imaging (88.27%), and C-reactive protein-based assay (87.65%) were better than those of mNGS, their specificities were generally low (20%-40%). Conclusion: The pathogens responsible for SI are complex and diverse. As a novel diagnostic method, mNGS exhibits a high sensitivity and extensive pathogen coverage for SI diagnosis. When combined with imaging and laboratory indicators, mNGS can significantly improve the accuracy of SI diagnosis and provide strong support for clinical treatment.

    Keywords: metagenomic next-generation sequencing, Microbial culture, Spinal infection, pathogens, Sensitivity, specificity

    Received: 24 May 2024; Accepted: 25 Nov 2024.

    Copyright: © 2024 Shi, Lin, Zheng, Ruan, Zhang, Liu, Xu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Yuhan Lin, Fuzhou Second General Hospital, Fuzhou, China
    Xuexin Zheng, Fuzhou Second General Hospital, Fuzhou, China
    Hongliang Ruan, Fuzhou Second General Hospital, Fuzhou, China
    Rui Zhang, Fuzhou Second General Hospital, Fuzhou, China
    Yinhuan Liu, Fuzhou Second General Hospital, Fuzhou, China
    Shaohan Xu, Fuzhou Second General Hospital, Fuzhou, China
    Huafeng Wang, Fuzhou Second General Hospital, Fuzhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.